Scynexis (SCYX) Profit After Tax Growth (5y) (2018 - 2026)
Scynexis (SCYX) Profit After Tax Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.86% |
| Mar 31, 2026 | -35.42% |
| Dec 31, 2025 | 17.99% |
| Sep 30, 2025 | -62.84% |
| Jun 30, 2025 | -1.53% |
| Mar 31, 2025 | 5.09% |
| Dec 31, 2024 | 21.06% |
| Sep 30, 2024 | 18.77% |
| Jun 30, 2024 | -11.46% |
| Mar 31, 2024 | 15.08% |
| Dec 31, 2023 | -64.61% |
| Sep 30, 2023 | -47.60% |
| Jun 30, 2023 | 67.96% |
| Mar 31, 2023 | -53.29% |
| Dec 31, 2022 | -13.71% |
| Sep 30, 2022 | -28.63% |
| Jun 30, 2022 | -26.02% |
| Mar 31, 2022 | -2.28% |
| Dec 31, 2021 | -53.38% |
| Sep 30, 2021 | 44.24% |